戻る Agenda
Evolving to Functional Service Providers (FSP): Successfully Transforming Existing Partnerships into FSP Relationships
Session Chair(s)
Andrew Townshend
Senior Vice President, Alliance Development
Syneos Health, United States
As expertise continues to transfer from pharma to CROs, how can the industry continue to drive improvement and innovation? One approach is the evolution of functional service provider (FSP) relationships. This forum brings together experts to discuss their successful approaches.
Learning Objective : Describe the challenges and benefits of converting to a functional service provider (FSP) relationship and how to manage the process; Explain how structures must change within to support this relationship; Identify how to make this transition while maintaining regulatory compliance and therapeutic excellence.
Speaker(s)
Panelist
Peter A Carberry, MD, MBA
Astellas Pharma Global Development, Inc., United States
Senior Vice President, Global Development Operations
Panelist
Gregg Dearhammer
IQVIA, United States
Senior Vice President, Data Sciences, Safety and Regulatory
Panelist
Gary Thompson, MS
Medidata Solutions, United States
Vice President, Strategic Consulting